Fig. 2From: Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositisCT thorax before (left, September 2021) and after (right, November 2021) therapy initiation with prednisolone, intravenous immunoglobulins, cotrimoxazole and ruxolitinib. Left: pleural round spot between middle lobe and upper lobe; ventral milk glass opacities. Right: Remission of milk glass opacity in all lobes of the lung with single patchy residuals in the middle lobe and basal upper lobe on the rightBack to article page